A Deep Dive on Research From the GI Cancers Symposium With Dr. Tanios Bekaii-Saab

By Chadi Nabhan, MD, MBA - Last Updated: March 22, 2024

In this special episode of Healthcare Unfiltered, Dr. Tanios Bekaii-Saab, of the Mayo Clinic, sits down with Dr. Chadi Nabhan to provide an insightful and comprehensive roundup of the most groundbreaking studies unveiled at the 2024 American Society of Clinical Oncology Gastrointestinal Cancers Symposium.

Dr. Bekaii-Saab delves into the realm of hepatocellular carcinoma, examining crucial, previously reported data from IMbrave050 and EMERALD-1. He also discusses developments in colorectal cancer, exploring the impact of KEYNOTE-177 and CheckMate 8HW. Moreover, Dr. Bekaii-Saab reviews the latest advancements in measurable residual disease assessment, with a focus on studies like BESPOKE and GALAXY, as well as the prognostic value of circulating tumor DNA assessment highlighted in COBRA.

This episode originally appeared on Healthcare Unfiltered.

Post Tags:GI Oncology
Latest News

May 24, 2024